NEW YORK (GenomeWeb News) – Intrexon today said that it plans to offer more than 8.3 million shares of its stock at between $14 and $16 per share in connection to its proposed initial public offering.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.
This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.